CYP19A1 and cancer: Participants reporting chemotherapy (57.84%), radiation (69.6%), Aromatase Inhibitors (22.6%) and/or Tamoxifen therapy (47.0%) may have experienced common side effects such as weight gain, deconditioning and cancer-related fatigue [67].